INCYTE CORP is 1.6x more valuable than Medpace Holdings, Inc. by market capitalization ($21.23 B vs $13.30 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INCY | MEDP |
|---|---|---|
| Market cap | $21.23 B | $13.30 B |
| US-listed rank | #595 | #785 |
| Revenue (latest FY) | $5.14B | $2.53B |
| Net income (latest FY) | $1.29B | $451.12M |
| Net margin | 25.0% | 17.8% |
| P/E (trailing FY) | 16.5 | 29.5 |
| SEC filings | 2,536 | 874 |
INCYTE CORP is 1.6x more valuable than Medpace Holdings, Inc. by market capitalization ($21.23 B vs $13.30 B).
In their latest fiscal years, INCYTE CORP reported $5.14B in revenue while Medpace Holdings, Inc. reported $2.53B.
Full pages: INCYTE CORP and Medpace Holdings, Inc., or browse the full rankings.